135 related articles for article (PubMed ID: 6293626)
1. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
[No Abstract] [Full Text] [Related]
2. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
Harris RH; Nichols R; Schmeling JW; Ramwell PW
Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
[No Abstract] [Full Text] [Related]
4. Role of ADP in platelet aggregation and fibrinogen binding induced by prostaglandin endoperoxides: studies in a patient with a selective defect of ADP-induced platelet aggregation.
Cattaneo M; Randi AM; Canciani MT; Lecchi A; Mannuci PM
Prog Clin Biol Res; 1988; 283():279-83. PubMed ID: 3211954
[No Abstract] [Full Text] [Related]
5. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane.
DiMinno G; Silver MJ; Cerbone AM; Riccardi G; Rivellese A; Mancini M; Thiagarajan P
Blood; 1985 Jan; 65(1):156-62. PubMed ID: 2981130
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting prostaglandin endoperoxide transformation: antibodies against PGH2.
Fitzpatrick FA; Pike JE
Prog Lipid Res; 1981; 20():179-82. PubMed ID: 7342082
[No Abstract] [Full Text] [Related]
7. Regulation of lymphatic contractility by arachidonate metabolites.
Johnston MG; Gordon JL
Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
[No Abstract] [Full Text] [Related]
8. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1982 Jul; 222(1):276-81. PubMed ID: 7086705
[TBL] [Abstract][Full Text] [Related]
9. The platelet fibrinogen receptor.
Peerschke EI
Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149
[No Abstract] [Full Text] [Related]
10. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
Jones RL; Wilson NH
Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
[No Abstract] [Full Text] [Related]
11. Platelet activation induced by a stable analogue of endoperoxides (U46619).
Zatta A; Prosdocimi M
Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
[No Abstract] [Full Text] [Related]
12. Platelet membranes, eicosanoid biosynthesis and putative endogenous calcium ionophores.
Carey F; Menashi S; Authi KS; Hack N; Lagarde M; Crawford N
Adv Exp Med Biol; 1985; 192():185-99. PubMed ID: 2422885
[No Abstract] [Full Text] [Related]
13. Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets.
Vrzheshch PV; Tatarintsev AV; Yershov DE; Varfolomeyev SD
Thromb Res; 1992 Jun; 66(5):537-47. PubMed ID: 1523610
[TBL] [Abstract][Full Text] [Related]
14. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
15. Desensitisation in human and rabbit blood platelets.
Hallam TJ; Ruggles PA; Scrutton MC; Wallis RB
Thromb Haemost; 1982 Jun; 47(3):278-84. PubMed ID: 7112500
[No Abstract] [Full Text] [Related]
16. Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
Cusack NJ; Hourani SM
Br J Pharmacol; 1981 Jun; 73(2):405-8. PubMed ID: 7236992
[TBL] [Abstract][Full Text] [Related]
17. BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man.
Gresele P; Deckmyn H; Arnout J; Lemmens J; Janssens W; Vermylen J
Lancet; 1984 May; 1(8384):991-4. PubMed ID: 6143969
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle.
Saussy DL; Mais DE; Knapp DR; Halushka PV
Circulation; 1985 Dec; 72(6):1202-7. PubMed ID: 2998641
[TBL] [Abstract][Full Text] [Related]
19. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
20. Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.
Di Minno G; Bertelé V; Cerletti C; de Gaetano G; Silver MJ
Thromb Res; 1982 Feb; 25(4):299-306. PubMed ID: 6803385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
